Obstructive sleep apnea affected nearly half of never-smokers with newly diagnosed lung cancer in a prospective study.
Among 77 enrolled patients, 67 were analyzed. The median age was 65, and 83.6% were women. Obstructive sleep apnea was identified in 47.8% of patients, with 20.9% having moderate-to-severe disease.
The prevalence of sleep apnea varied by cancer stage but was not statistically significant. Researchers found no link between sleep apnea severity and advanced-stage disease.
Clinicians are urged to recognize and manage sleep apnea in this high-risk group.